Metastasis: Tumor cells becoming MENAcing

Trends in Cell Biology

Volumn 21, Issue 2, 2011, Pages 81-90

  Gertler, Frank ^a   Condeelis, John ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN MENA; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

CELL INVASION; CELL MIGRATION; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR CELL;

ACTINS; ANIMALS; BREAST NEOPLASMS; CELL MOVEMENT; GENE EXPRESSION PROFILING; HUMANS; MICROFILAMENT PROTEINS; NEOPLASM METASTASIS; TUMOR MICROENVIRONMENT;

EID: 79151474408     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2010.10.001     Document Type: Review

References (111)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
2. Mantovani A., et al. Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma. Eur. J. Cancer 1981, 17:71-76.
3. Giavazzi R., et al. Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. Br. J. Cancer 1980, 42:462-472.
4. Milas L., et al. Spontaneous metastasis: random or selective? Clin. Exp. Metastasis 1983, 1:309-315.
5. Wyckoff J., et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 2004, 64:7022-7029.
6. van't Veer L.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
7. Ramaswamy S., et al. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 2003, 33:49-54.
8. Wang W., et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res. 2004, 64:8585-8594.
9. Wang W., et al. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol. 2005, 15:138-145.
10. Wang W., et al. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res. 2007, 67:3505-3511.
11. Condeelis J., et al. The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu. Rev. Cell Dev. Biol. 2005, 21:695-718.
12. Leek R.D., Harris A.L. Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 2002, 7:177-189.
13. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
14. Giraudo E., et al. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J. Clin. Invest. 2004, 114:623-633.
15. Condeelis J., Segall J.E. Intravital imaging of cell movement in tumours. Nat. Rev. Cancer 2003, 3:921-930.
16. Wyckoff J.B., et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007, 67:2649-2656.
17. Kedrin D., et al. Intravital imaging of metastatic behavior through a mammary imaging window. Nat. Methods 2008, 5:1019-1021.
18. Klein C.A., et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002, 360:683-689.
19. Radisky D., et al. Tumors are unique organs defined by abnormal signaling and context. Semin. Cancer Biol. 2001, 11:87-95.
20. Di Modugno F., et al. Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response. Int. J. Cancer 2004, 109:909-918.
21. Di Modugno F., et al. The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors. Clin. Cancer Res. 2006, 12:1470-1478.
22. Philippar U., et al. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev. Cell 2008, 15:813-828.
23. Robinson B.D., et al. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin. Cancer Res. 2009, 15:2433-2441.
24. Sidani M., et al. Probing the microenvironment of mammary tumors using multiphoton microscopy. J. Mammary Gland Biol. Neoplasia 2006, 11:151-163.
25. Sahai E. Illuminating the metastatic process. Nat. Rev. Cancer 2007, 7:737-749.
26. Timpson P., et al. Quantitative real-time imaging of molecular dynamics during cancer cell invasion and metastasis in vivo. Cell Adh. Migr. 2009, 3:351-354.
27. Perentes J.Y., et al. In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts. Nat. Methods 2009, 6:143-145.
28. Egeblad M., et al. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. Dis. Model Mech. 2008, 1:155-167.
29. Yamaguchi H., et al. Invadopodia and podosomes in tumor invasion. Eur. J. Cell Biol. 2006, 85:213-218.
30. Kedrin, D. et al. (2007) Imaging tumor cell movement in vivo. Curr. Protoc. Cell Biol. Chapter 19, Unit 19.17.
31. Goswami S., et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 2005, 65:5278-5283.
32. Wang W., et al. Gene expression analysis on small numbers of invasive cells collected by chemotaxis from primary mammary tumors of the mouse. BMC Biotechnol. 2003, 3:13.
33. Goswami S., et al. Breast cancer cells isolated by chemotaxis from primary tumors show increased survival and resistance to chemotherapy. Cancer Res. 2004, 64:7664-7667.
34. Wang W., et al. The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J. Cell Biol. 2006, 173:395-404.
35. Xue C., et al. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res. 2006, 66:192-197.
36. Gurzu S., et al. The immunohistochemical aspects of protein Mena in cervical lesions. Rom. J. Morphol. Embryol. 2009, 50:213-216.
37. Gurzu S., et al. The expression of cytoskeleton regulatory protein Mena in colorectal lesions. Rom. J. Morphol. Embryol. 2008, 49:345-349.
38. Toyoda A., et al. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. Int. J. Oncol. 2009, 34:53-60.
39. Junnila S., et al. Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines. BMC Cancer 2010, 10:73.
40. Gertler F.B., et al. Genetic suppression of mutations in the Drosophila abl proto-oncogene homolog. Science 1990, 248:857-860.
41. Gertler F.B., et al. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 1996, 87:227-239.
42. Krause M., et al. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu. Rev. Cell Dev. Biol. 2003, 19:541-564.
43. Drees F., Gertler F.B. Ena/VASP: proteins at the tip of the nervous system. Curr. Opin. Neurobiol. 2008, 18:53-59.
44. Gates J., et al. Enabled plays key roles in embryonic epithelial morphogenesis in Drosophila. Development 2007, 134:2027-2039.
45. Sheffield M., et al. C. elegans Enabled exhibits novel interactions with N-WASP, Abl, and cell-cell junctions. Curr. Biol. 2007, 17:1791-1796.
46. Bear J.E., et al. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 2002, 109:509-521.
47. Furman C., et al. Ena/VASP is required for endothelial barrier function in vivo. J. Cell Biol. 2007, 179:761-775.
48. Scott J.A., et al. Ena/VASP proteins can regulate distinct modes of actin organization at cadherin-adhesive contacts. Mol. Biol. Cell 2006, 17:1085-1095.
49. Menzies A.S., et al. Mena and vasodilator-stimulated phosphoprotein are required for multiple actin-dependent processes that shape the vertebrate nervous system. J. Neurosci. 2004, 24:8029-8038.
50. Lebrand C., et al. Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1. Neuron 2004, 42:37-49.
51. Dent E.W., et al. Filopodia are required for cortical neurite initiation. Nat. Cell Biol. 2007, 9:1347-1359.
52. Kwiatkowski A.V., et al. Ena/VASP Is required for neuritogenesis in the developing cortex. Neuron 2007, 56:441-455.
53. Lanier L.M., et al. Mena is required for neurulation and commissure formation. Neuron 1999, 22:313-325.
54. Han Y.H., et al. Requirement of a vasodilator-stimulated phosphoprotein family member for cell adhesion, the formation of filopodia, and chemotaxis in dictyostelium. J. Biol. Chem. 2002, 277:49877-49887.
55. Neel N.F., et al. VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. J. Cell Sci. 2009, 122:1882-1894.
56. Chédotal A. Slits and their receptors. Adv. Exp. Med. Biol. 2007, 621:65-80.
57. Gupton S., Gertler F.B. Integrin signaling switches the cytoskeletal and exocytic machinery that drives neuritogenesis. Dev. Cell 2010, 18:725-736.
58. Bear J.E., Gertler F.B. Ena/VASP: towards resolving a pointed controversy at the barbed end. J. Cell Sci. 2009, 122:1947-1953.
59. Skoble J., et al. Pivotal role of VASP in Arp2/3 complex-mediated actin nucleation, actin branch-formation, and Listeria monocytogenes motility. J. Cell Biol. 2001, 155:89-100.
60. Plastino J., et al. Actin filaments align into hollow comets for rapid VASP-mediated propulsion. Curr. Biol. 2004, 14:1766-1771.
61. Lacayo C.I., et al. Emergence of large-scale cell morphology and movement from local actin filament growth dynamics. PLoS Biol. 2007, 5:e233.
62. Barzik M., et al. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J. Biol. Chem. 2005, 280:28653-28662.
63. Applewhite D.A., et al. Ena/VASP proteins have an anti-capping independent function in filopodia formation. Mol. Biol. Cell 2007, 18:2579-2591.
64. Gupton S.L., Gertler F.B. Filopodia: the fingers that do the walking. Sci. STKE 2007, 2007:re5.
65. Pino M.S., et al. Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines. Clin. Cancer Res. 2008, 14:4943-4950.
66. McDonnell A.V., et al. Paircoil2: improved prediction of coiled coils from sequence. Bioinformatics 2006, 22:356-358.
67. Di Modugno F., et al. Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines. Cancer Res. 2007, 67:2657-2665.
68. Goswami S., et al. Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Clin. Exp. Metastasis 2009, 26:153-159.
69. Warzecha C.C., et al. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol. Cell 2009, 33:591-601.
70. Shen S., et al. MADS+: discovery of differential splicing events from Affymetrix exon junction array data. Bioinformatics 2010, 26:268-269.
71. Venables J.P., et al. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 2009, 16:670-676.
72. Lambrechts A., et al. cAMP-dependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J. Biol. Chem. 2000, 275:36143-36151.
73. Wang W., et al. The cofilin pathway in breast cancer invasion and metastasis. Nat. Rev. Cancer 2007, 7:429-440.
74. Trichet L., et al. Relaxing the actin cytoskeleton for adhesion and movement with Ena/VASP. J. Cell Biol. 2008, 181:19-25.
75. Pasic L., et al. Ena/VASP proteins capture actin filament barbed ends. J. Biol. Chem. 2008, 283:9814-9819.
76. Ferron F., et al. Structural basis for the recruitment of profilin-actin complexes during filament elongation by Ena/VASP. EMBO J. 2007, 26:4597-4606.
77. Schirenbeck A., et al. The bundling activity of vasodilator-stimulated phosphoprotein is required for filopodium formation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7694-7699.
78. Breitsprecher D., et al. Clustering of VASP actively drives processive, WH2 domain-mediated actin filament elongation. EMBO J. 2008, 27:2943-2954.
79. Hansen S., Mullins D. VASP is a processive actin polymerase that requires monomeric actin for barbed end association. J. Cell Biol. 2010, 191:571-584.
80. Grosse R., et al. A role for VASP in RhoA-Diaphanous signalling to actin dynamics and SRF activity. EMBO J. 2003, 22:3050-3061.
81. Homem C.C., Peifer M. Exploring the roles of diaphanous and enabled activity in shaping the balance between filopodia and lamellipodia. Mol. Biol. Cell 2009, 20:5138-5155.
82. Lim K.B., et al. The Cdc42 effector IRSp53 generates filopodia by coupling membrane protrusion with actin dynamics. J. Biol. Chem. 2008, 283:20454-20472.
83. Robens J.M., et al. Regulation of IRSp53-dependent filopodial dynamics by antagonism between 14-3-3 binding and SH3-mediated localization. Mol. Cell Biol. 2010, 30:829-844.
84. Dominguez R. Actin filament nucleation and elongation factors--structure-function relationships. Crit. Rev. Biochem. Mol. Biol. 2009, 44:351-366.
85. Birbach A. Profilin, a multi-modal regulator of neuronal plasticity. Bioessays 2008, 30:994-1002.
86. Geese M., et al. Contribution of Ena/VASP proteins to intracellular motility of Listeria requires phosphorylation and proline-rich core but not F-actin binding or multimerization. Mol. Biol. Cell 2002, 13:2383-2396.
87. Chereau D., Dominguez R. Understanding the role of the G-actin-binding domain of Ena/VASP in actin assembly. J. Struct. Biol. 2006, 155:195-201.
88. Bachmann C., et al. The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation. J. Biol. Chem. 1999, 274:23549-23557.
89. Huttelmaier S., et al. Characterization of the actin binding properties of the vasodilator-stimulated phosphoprotein VASP. FEBS Lett. 1999, 451:68-74.
90. Kang F., et al. Profilin interacts with the Gly-Pro-Pro-Pro-Pro-Pro sequences of vasodilator-stimulated phosphoprotein (VASP): implications for actin-based Listeria motility. Biochemistry 1997, 36:8384-8392.
91. Loureiro J.J., et al. Critical roles of phosphorylation and actin binding motifs, but not the central proline-rich region, for Ena/vasodilator-stimulated phosphoprotein (VASP) function during cell migration. Mol. Biol. Cell 2002, 13:2533-2546.
92. Harbeck B., et al. Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin. J. Biol. Chem. 2000, 275:30817-30825.
93. Ahern-Djamali S.M., et al. Mutations in Drosophila enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains. Mol. Biol. Cell 1998, 9:2157-2171.
94. Kuhnel K., et al. The VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17027-17032.
95. Ball L.J., et al. EVH1 domains: structure, function and interactions. FEBS Lett. 2002, 513:45-52.
96. Niebuhr K., et al. A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family. EMBO J. 1997, 16:5433-5444.
97. Smith G.A., Portnoy D.A. How the Listeria monocytogenes ActA protein converts actin polymerization into a motile force. Trends Microbiol. 1997, 5:272-276.
98. Auerbuch V., et al. Ena/VASP proteins contribute to Listeria monocytogenes pathogenesis by controlling temporal and spatial persistence of bacterial actin-based motility. Mol. Microbiol. 2003, 49:1361-1375.
99. Hoffman L.M., et al. Genetic ablation of zyxin causes Mena/VASP mislocalization, increased motility, and deficits in actin remodeling. J. Cell Biol. 2006, 172:771-782.
100. Krause M., et al. Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics. Dev. Cell 2004, 7:571-583.
101. Rodriguez-Viciana P., et al. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol. Cell Biol. 2004, 24:4943-4954.
102. Michael M., et al. c-Abl, Lamellipodin, and Ena/VASP proteins cooperate in dorsal ruffling of fibroblasts and axonal morphogenesis. Curr. Biol. 2010, 20:783-791.
103. Lyulcheva E., et al. Drosophila pico and its mammalian ortholog lamellipodin activate serum response factor and promote cell proliferation. Dev. Cell 2008, 15:680-690.
104. Adler C.E., et al. UNC-6/Netrin induces neuronal asymmetry and defines the site of axon formation. Nat. Neurosci. 2006, 9:511-518.
105. Chang C., et al. MIG-10/lamellipodin and AGE-1/PI3K promote axon guidance and outgrowth in response to slit and netrin. Curr. Biol. 2006, 16:854-862.
106. Quinn C.C., et al. UNC-6/netrin and SLT-1/slit guidance cues orient axon outgrowth mediated by MIG-10/RIAM/lamellipodin. Curr. Biol. 2006, 16:845-853.
107. Boukhelifa M., et al. Palladin is a novel binding partner for Ena/VASP family members. Cell Motil. Cytoskeleton 2004, 58:17-29.
108. Goicoechea S.M., et al. Palladin contributes to invasive motility in human breast cancer cells. Oncogene 2009, 28:587-598.
109. Chin Y.R., Toker A. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol. Cell 2010, 38:333-344.
110. Boeda B., et al. Tes, a specific Mena interacting partner, breaks the rules for EVH1 binding. Mol. Cell 2007, 28:1071-1082.
111. Strickland P., et al. Slit2 and netrin 1 act synergistically as adhesive cues to generate tubular bi-layers during ductal morphogenesis. Development 2006, 133:823-832.